Next Article in Journal
An Optimization Model for a Wetland Restoration Project under Uncertainty
Previous Article in Journal
Association Between Sport Participation, Body Composition, Physical Fitness, and Social Correlates Among Adolescents: The PAHL Study
Previous Article in Special Issue
Shedding Light on the Shade: How Nurseries Protect Their Children from Ultraviolet Radiation
Article Menu
Issue 12 (December) cover image

Export Article

Int. J. Environ. Res. Public Health 2018, 15(12), 2794; doi:10.3390/ijerph15122794

Commentary
Sun Exposure Public Health Directives
1
Department of Public Health Sciences, Medical University of South Carolina, Charleston, SC 29425, USA
2
Department of Dermatology, Leiden University Medical Center, 2333 ZA Leiden, The Netherlands
*
Author to whom correspondence should be addressed.
Received: 9 October 2018 / Accepted: 3 December 2018 / Published: 10 December 2018

Abstract

:
There have been many public health recommendations for avoiding UV radiation exposures. This is primarily due to concerns about skin cancer and especially melanoma, the most serious type of skin cancer. However, UV radiation is also known as the primary source of vitamin D and other compounds needed for good health. This brief commentary lists several of the many important recent studies of adverse health effects associated with low sun exposure, including some specific cancers, multiple sclerosis, diabetes, cardiovascular disease, autism, Alzheimer’s disease, and age-related macular degeneration. Our conclusion is that non-burning UV exposure is a health benefit and—in moderation—should be recommended as such.
Keywords:
UV radiation; vitamin D; nitric oxide; melanoma; cancer; cardiovascular

1. Commentary

There is currently considerable misinformation and confusion in the public health sector regarding the effects of sun exposure on human health. The prevailing public health message is, and has been for the past several decades, that “over exposure” (undefined) to the sun causes skin cancer, including melanoma, and health benefits of sun exposure are limited to bone health. Since “over exposure” is not defined, the public is led to believe that sun exposure should be avoided and that avoidance of sun exposure is risk-free. The prevailing public health message also incorrectly states that vitamin D supplements are an adequate substitute for sun exposure. This public health message is potentially causing significant harm to public health and should be changed immediately. Examples of this public health message are currently extant in the United States [1,2,3], the United Kingdom [4], Australia [5], and New Zealand [6].
An examination of the current state of the scientific research shows that (i) severe sunburns are linked to increased risk of melanoma but non-burning sun exposure is linked to reduced risk of melanoma [7,8,9]; (ii) squamous cell carcinoma of the skin (SCC) is linked to outdoor professions and correspondingly a great deal of cumulative lifetime sun exposure (20,000+ hours for northern Europeans [10] and 50,000+ hours for southern Europeans [11,12]); (iii) the linkage with UV exposure is less clear for basal cell carcinoma of the skin (BCC) than for SCC, but BCC appears to be linked mostly to sunburns rather than to cumulative lifetime sun exposure [12,13]; and (iv) the health risks of sun avoidance are indicated to be significant. One recent study estimated that approximately 12% of U.S. deaths (340,000 persons per year) may be linked to inadequate sun exposure [14], and another all-cause mortality study found that avoidance of sun exposure is a risk factor for death of a similar magnitude as smoking [15].
It is known that UV-A from sun exposure increases circulating nitric oxide, decreasing hypertension and cardiovascular disease [16]. It has been estimated that 25(OH)D concentrations (a marker for sun exposure) of less than 12 ng/mL vs. more than 33 ng/mL are correlated to 100% increased risk of colorectal cancer [17]; 25(OH)D concentrations of 19.8 ng/mL vs. 27 ng/mL are correlated with a 37% increased risk of breast cancer [18]; 25(OH)D concentrations of less than 20 ng/mL vs. more than 60 ng/mL are correlated with a 400% increased risk of breast cancer [19]; 25(OH)D concentrations of 14 ng/mL vs. 32 ng/mL are correlated with a 79% increased risk of death from breast cancer in breast cancer patients [20]. For non-cancer effects, a 25(OH)D concentration of less than 5 ng/mL vs. more than 20 ng/mL is correlated with a 35% increased risk of type 2 diabetes [21]. Serum 25(OH)D concentrations of less than 20 ng/mL are correlated with a 64% increased risk of metabolic syndrome in the elderly [22]. Serum 25(OH)D concentrations of below 10 ng/mL vs. above 20 ng/mL are correlated with a 122% increased risk of Alzheimer’s disease [23]. Serum 25(OH)D concentrations of below 12 ng/mL vs. above 20 ng/mL are correlated with a 43% increased risk of multiple sclerosis in women [24]. Serum 25(OH)D concentrations of less than 12 ng/mL vs. more than 12 ng/mL in early pregnancy are correlated with a 90% increased risk of multiple sclerosis in offspring [25]. Serum 25(OH)D concentrations in neonates and pregnant mothers at mid-gestation of less than 10 ng/mL vs. more than 20 ng/mL are correlated with a 142% increased risk of autism in offspring [26]. Lower vs. higher sun exposure in pregnancy is correlated with a 67% increased risk of type 1 diabetes in offspring [27]. Serum 25(OH)D concentrations of less than 12 ng/mL vs. more than 12 ng/mL in women who had a genetic risk for age-related macular degeneration (AMD) are correlated with a 6.7-fold increase in the risk of developing AMD [28]. Inadequate sun exposure has also been tied to increased risk of myopia [29], psoriasis [30], non-alcoholic fatty liver disease [31], eczema in infants [32], and cognitive problems [33]. A more detailed description of these and other similar studies are to be found in Hoel et al., 2016 [34]. The problem of inadequate sun exposure in the United States is more severe for dark skinned individuals than for those with light skin. Identified mediators produced by sun exposure include vitamin D, nitric oxide, dopamine, beta-endorphin, urocanic acid, and glutamate. Vitamin D supplementation is not an adequate substitute for sun exposure [35].
The incidence of melanoma in the United States has steadily increased at an annual rate of 3–4% from 1 case per 100,000 in 1935, when accurate records were established, to 25.8 cases per 100,000 in 2015. According to the Centers for Disease Control and Prevention (CDC), the prevalence of sunburns increased from 32% of all white adults in 1999 to 34% in 2004 [36] and up to 50% in 2012 [37]. Among white adolescents aged 12–18 in 1999, 83% reported at least one sunburn in the previous summer and 36% reported three or more sunburns in the previous summer [38]. Public health officials, such as the U.S.’s CDC, advise against “overexposure” when they should be specifically advising against sunburns. This combined with dubiously advising against moderate sun exposure and the incorrect assertion that tanned skin provides insignificant protection against sunburn may have contributed to this increase in melanoma incidence.
While there is still vigorous debate within the scientific community regarding the desirable level of serum 25(OH)D, many scientists believe, and the scientific studies discussed above indicate, that it is between 30 and 60 ng/mL (75–150 nmol/L). A well-controlled study with simulated solar UV led to the estimate that about a half hour of midday summer sun three times a week in summer clothing would be enough for 90% of white Caucasians to achieve a serum 25(OH)D level equal to or greater than 20 ng/mL (50 nmol/L) at latitudes 30 to 55 degrees [39]. More exposure would be needed to achieve desirable levels of 30–60 ng/mL (75–150 nmol/L), and more exposure would be required in other seasons, at earlier or later times of the day, at higher latitudes, and for persons with darker skin. In light of all the variables involved and the fact that each person is different, the recommended course of action is for each person to have periodic serum 25(OH)D tests and to adjust sun exposure as necessary to reach desired levels of 25(OH)D while taking great care to avoid sunburns. If all sunburns are avoided, these levels can probably be achieved without any appreciable increase in the risk of melanoma and without significant increase in the risk of SCC or BCC. Data from the National Health and Nutrition Examination Survey (NHANES) show that 77% of Americans had serum 25(OH)D concentrations of less than 30 ng/mL in 2001–2004, up from 55% in 1988–1994 [40]. It is noted that the comprehensive 2010 vitamin D study [35] by the Institute of Medicine (IOM; now named the National Academy of Medicine) is often misinterpreted as standing for the proposition that 20 ng/mL is an adequate level of serum 25(OH)D. The purpose of the IOM study was, as the title indicates, to determine the appropriate recommendation for the dietary reference intake (DRI) of vitamin D supplements. The study correctly concluded that vitamin D supplements had not been shown to have any health benefits beyond skeletal health, and that for purposes of skeletal health a serum 25(OH)D level of 20 ng/mL was sufficient [35].

2. Conclusions

The public health directive regarding sun exposure and human health should be adjusted to reflect current scientific knowledge. We recommend a public health directive as follows:
All persons in the world regardless of skin color or latitude of residence, other than those with extraordinary sensitivity to sunlight, should get enough sun exposure to maintain a serum 25(OH)D level well over 20 ng/mL (desirably at 30–60 ng/mL) while taking care to avoid sunburn.
As with all things in life, we must maintain a good balance, in this case between beneficial and adverse health effects from sunlight. Besides being impractical, completely avoiding sun exposure appears to be unhealthy in many ways. The responsibility for the proper health directive within the U.S. appears to lie with the Centers for Disease Control and Prevention (CDC), and within the CDC with the National Center for Chronic Disease Prevention and Health Promotion. Responsible agencies in Europe and the rest of the world include the World Health Organization, Cancer Research U.K., the French Ministry of Social Affairs and Health, the Ministry of Health and Cancer Society of New Zealand, and Cancer Council Australia.

Author Contributions

Writing, original draft, D.G.H.; review & editing, F.R.G.

Funding

This research received no external funding. However, page charges were obtained from the Canadian Vitamin D Association.

Conflicts of Interest

The authors declare no conflict of interest.

References

  1. Geller, A.C.; Jablonski, N.G.; Pagoto, S.L.; Hay, J.L.; Hillhouse, J.; Buller, D.B.; Kenney, W.L.; Robinson, M.D.; Weller, R.B.; Moreno, M.A.; et al. Interdisciplinary Perspectives on Sun Safety. JAMA Dermatol. 2018, 154, 88–92. [Google Scholar] [CrossRef]
  2. Sun Exposure. Available online: https://www.nc.cdc.gov/travel/page/sun-exposure (accessed on 29 October 2018).
  3. Most schools can do more to help students stay sun safe. Available online: https://www.cdc.gov/cancer/dcpc/research/articles/sun_safe_schools.htm (accessed on 29 October 2018).
  4. Consensus Vitamin D position statement. Available online: https://www.nhs.uk/livewell/summerhealth/documents/concensus_statement%20_vitd_dec_2010.pdf (accessed on 29 October 2018).
  5. Position statement - Sun exposure and vitamin D - risks and benefits. Available online: https://www.cancer.org.au/policy/Position_statement_-_Risks_and_benefits_of_sun_exposure#Key_messages_and_recommendations (accessed on 29 October 2018).
  6. Consensus Statement on Vitamin D and Sun Exposure in New Zealand. Available online: https://www.health.govt.nz/system/files/documents/publications/vitamind-sun-exposure.pdf (accessed on 29 October 2018).
  7. Gandini, S.; Sera, F.; Cattaruzza, M.S.; Pasquini, P.; Abeni, D.; Boyle, P.; Melchi, C.F. Meta-analysis of risk factors for cutaneous melanoma: II. Sun exposure. Eur. J. Cancer 2005, 41, 45–60. [Google Scholar] [CrossRef] [PubMed]
  8. Van Schanke, A.; Jongsma, M.J.; Bisschop, R.; van Venrooij, G.M.C.A.L.; Rebel, H.; de Gruijl, F.R. Single UVB Overexposure Stimulates Melanocyte Proliferation in Murine Skin, in Contrast to Fractionated or UVA-1 Exposure. J. Investig. Dermatol. 2005, 124, 241–247. [Google Scholar] [CrossRef] [PubMed]
  9. Vuong, K.; McGeechan, K.; Armstrong, B.K.; AMFS Investigators, GEM Investigators. Cust AE Occupational sun exposure and risk of melanoma according to anatomical site. Int. J. Cancer 2014, 134, 2735–2741. [Google Scholar] [CrossRef] [PubMed]
  10. Kennedy, C.; Bajdik, C.D.; Willemze, R.; de Gruijl, F.R.; Bavinck, J.N.B. The Influence of Painful Sunburns and Lifetime Sun Exposure on the Risk of Actinic Keratoses, Seborrheic Warts, Melanocytic nevi, Atypical Nevi, and Skin Cancer. J. Investig. Dermatol. 2003, 120, 1087–1093. [Google Scholar] [CrossRef] [PubMed]
  11. Rosso, S.; Joris, F.; Zanetti, R. Risk of Basal and Squamous Cell Carcinoma of the Skin in Sion, Switzerland: A Case-Control Study. Tumori 1999, 85, 435–442. [Google Scholar] [CrossRef] [PubMed]
  12. Rosso, S.; Zanetti, R.; Martinez, C.; Tormo, M.J.; Schraub, S.; Sancho-Garnier, H.; Franceschi, S.; Gafa, L.; Perea, E.; Navarro, C.; et al. The multicentre south European study “Helios” II: Different sun exposure patterns in the aetiology of basal cell and squamous cell carcinomas of the skin. Brit. J. Cancer 1996, 73, 1447–1454. [Google Scholar] [CrossRef] [PubMed]
  13. Armstrong, B.K.; Kricker, A. The epidemiology of UV induced skin cancer. J. Photochem. Photobiol. B 2001, 63, 8–18. [Google Scholar] [CrossRef]
  14. Chowdury, R.; Kunutsor, S.; Vitezova, A.; Oliver-Williams, C.; Chowdhury, S.; Kiefte-de-Jong, J.C.; Khan, H.; Baena, C.P.; Prabhakaran, D.; Hoshen, M.B.; et al. Vitamin D and risk of cause specific death: Systematic review and meta-analysis of observational cohort and randomised intervention studies. BMJ 2014, 348, g1903. [Google Scholar] [CrossRef]
  15. Lindqvist, P.G.; Epstein, E.; Nielsen, K.; Landin-Olsson, M.; Ingvar, C.; Olsson, H. Avoidance of sun exposure as a risk factor for major causes of death: A competing risk analysis of the Melanoma in Southern Sweden cohort. J. Int. Med. 2016. [Google Scholar] [CrossRef]
  16. Liu, D.; Fernandez, B.O.; Hamilton, A.; Lang, N.N.; Gallagher, J.M.C.; Newby, D.E.; Feelisch, M.; Weller, R.B. UVA Irradiation of Human Skin Vasodilates Arterial Vasculature and Lowers Blood Pressure Independently of Nitric Oxide Synthase. J. Investig. Dermatol. 2014, 134, 1839–1846. [Google Scholar] [CrossRef]
  17. Gorham, E.D.; Garland, C.F.; Garland, F.C.; Grant, W.B.; Mohr, S.B.; Lipkin, M.; Newmark, H.L.; Giovannucci, E.; Wei, M.; Holick, M.F. Optimal Vitamin D Status for Colorectal Cancer Prevention. Am. J. Prev. Med. 2007, 32, 210–216. [Google Scholar] [CrossRef]
  18. Engel, P.; Fagherazzi, G.; Boutten, A.; Dupre, T.; Mesrine, S.; Boutron-Rualt, M.C.; Clavel-Chapelon, F. Serum 25(OH)D Vitamin D and Risk of Breast cancer: A Nested Case-Control Study from the French E3N Cohort. Cancer Epidemiol. Biolmark. Prev. 2010, 19, 2341–2350. [Google Scholar] [CrossRef] [PubMed]
  19. McDonnell, S.L.; Baggerly, C.A.; French, C.B.; Baggerly, L.L.; Garland, C.F.; Gorham, E.D.; Hollis, B.S.; Trump, D.L.; Lappe, J.M. Brest cancer risk markedly lower with serum 25-hydroxyvitamin D concentrations more than 60 ng/mL vs less than 20 ng/mL (150 vs 50 nmol/L): Pooled analysis of two randomized trials and a prospective cohort. PLoS ONE 2018, 13, e0199265. [Google Scholar] [CrossRef]
  20. Mohr, S.B.; Gorham, E.D.; Kim, J.; Hofflich, H.; Garland, C.F. Meta-analysis of Vitamin D Sufficiency for Improving Survival of Patients with Breast Cancer. Anticancer Res. 2014, 34, 1163–1166. [Google Scholar] [PubMed]
  21. Afzal, S.; Bojesen, S.E.; Nordestgaard, B.G. Low 25-Hydroxyvitamin D and Risk of Type 2 Diabetes: A Prospective Cohort Study and Metaanalysis. Clin. Chem. 2013, 59, 381–391. [Google Scholar] [CrossRef] [PubMed]
  22. Vitezova, A.; Zillikens, M.C.; van Herpt, T.T.W.; Sijbrands, E.J.G.; Hofman, A.; Uitterlinden, A.G.; Franco, O.H.; Kiefte-de Jong, J.C. Vitamin D status and metabolic syndrome in the elderly: The Rotterdam Study. Eur. J. Endocrinol. 2015, 172, 327–335. [Google Scholar] [CrossRef]
  23. Littlejohns, T.J.; Henley, W.E.; Lang, I.A.; Annweiler, C.; Beauchet, O.; Chaves, P.H.M.; Fried, L.; Kestenbaum, G.R.; Kuller, L.H.; Langa, K.M.; et al. Vitamin D the risk of dementia and Alzheimer disease. Neurology 2014, 83, 920–928. [Google Scholar] [CrossRef]
  24. Munger, K.L.; Hongell, K.; Aivo, J.; Soilu-Hanninen, M.; Surcel, H.-M.; Ascherio, A. 25-Hydroxyvitamin D deficiency and risk of MS among women in the Finnish Maternity Cohort. Neurology 2017, 89, 1578–1583. [Google Scholar] [CrossRef]
  25. Munger, K.L.; Hongell, K.; Aivo, J.; Soilu-Hänninen, M.; Surcel, H.-M.; Ascherio, A. Vitamin D Status During Pregnancy and Risk of Multiple Sclerosis in Offspring of Women in the Finnish Maternity Cohort. JAMA Neurol. 2016, 73, 515–519. [Google Scholar] [CrossRef]
  26. Vinkhuyzen, A.A.E.; Eyles, D.W.; Burne, T.H.J.; Blanken, L.M.E.; Kruithof, C.J.; Verhulst, F.; White, T.; Jaddoe, V.W.; Tiemeier, H.; McGrath, J.J. Gestational vitamin D deficiency and autism spectrum disorder. BJPsych Open 2017, 3, 85–90. [Google Scholar] [CrossRef] [PubMed]
  27. Jacobsen, R.; Frederiksen, P.; Heitmann, B.L. Exposure to sunshine early in life preventeddevelopment of type 1diabetes in Danish boys. J. Pediatr. Endocrinol. Metab. 2016, 19, 417–424. [Google Scholar]
  28. Millen, A.E.; Meyers, K.J.; Liu, Z.; Engelman, C.D.; Wallace, R.B.; LeBlanc, E.S.; Tinker, L.F.; Lyengar, S.K.; Robinson, J.G.; Sarto, G.E.; et al. Association Between Vitamin D Status and Age-Related Macular Degeneration by Genetic Risk. JAMA Ophthalmol. 2015, 133, 1171–1179. [Google Scholar] [CrossRef] [PubMed]
  29. French, A.N.; Ashby, R.S.; Morgan, I.G.; Rose, K.A. Time outdoors and the prevention of myopia. Exp. Eye Res. 2013, 114, 58–68. [Google Scholar] [CrossRef] [PubMed]
  30. Gisondi, P.; Rossini, M.; De Cesare, A.; Idolazzi, L.; Farini, S.; Beltrami, G.; Peris, K.; Girolomini, G. Vitamin D status in patients with chronic plaque psoriasis. Br. J. Dermatol. 2012, 166, 505–510. [Google Scholar] [CrossRef] [PubMed]
  31. Gorman, S.; Black, L.J.; Feelisch, M.; Hart, P.H.; Weller, R. Can Skin Exposure to Sunlight Prevent Liver Inflammation? Nutrients 2015, 7, 3219–3239. [Google Scholar] [CrossRef]
  32. Rueter, K.; Jones, A.P.; Siafarikas, A.; Lim, E.-M.; Bear, N.; Noakes, P.S.; Prescott, S.L.; Palmer, D.J. Direct infant UV light exposure is associated with eczema and immune development. J. Allergy Clin. Immunol. 2018. [Google Scholar] [CrossRef]
  33. Zhu, H.; Wang, N.; Yao, L.; Chen, Q.; Zhang, R.; Qian, J.; Hou, Y.; Guo, W.; Fan, S.; Liu, S.; et al. Moderate UV exposure enhances learning and memory by promoting a novel glutamate biosynthetic pathway the brain. Cell 2018, 173, 1716–1727. [Google Scholar] [CrossRef]
  34. Hoel, D.G.; Berwick, M.; de Gruijl, F.R.; Holick, M.F. The risks and benefits of sun exposure. Dermato-Endocrinol. 2016, 8, e1248325. [Google Scholar] [CrossRef]
  35. Institute of Medicine. Dietary Reference Intakes for Calcium and Vitamin D; National Academies Press: Washington, DC, USA, 2010; page S-11 and page 8–7. [Google Scholar]
  36. MMWR Weekly Report June 1, 2007; CDC: Atlanta, GA, USA, 2007; Volume 56, pp. 524–528.
  37. MMWR Weekly Report May 11, 2012; CDC: Atlanta, GA, USA, 2012; Volume 61, pp. 317–322.
  38. Geller, A.C.; Colditz, G.; Oliveria, S.; Emmons, K.; Jorgensen, C.; Aweh, G.N.; Frazier, A.L. Use of sunscreen, sunburning rates, and tanning bed use among more than 10,000 US children and adolescents. Pediatrics 2002, 109, 1009–1014. [Google Scholar] [CrossRef]
  39. Webb, A.R.; Kift, R.; Berry, J.L.; Rhodes, L.E. The vitamin D debate: Translating controlled experiments into reality of human sun exposure times. Photochem. Photobiol. 2011, 87, 741–745. [Google Scholar] [CrossRef] [PubMed]
  40. Ginde, A.A.; Liu, M.C.; Camargo, C.A. Demographic differences and trends of vitamin D insufficiency in the US population, 1988–2004. Arch. Intern Med. 2009, 169, 626–632. [Google Scholar] [CrossRef] [PubMed]

© 2018 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
Int. J. Environ. Res. Public Health EISSN 1660-4601 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert
Back to Top